FIELD: chemistry; biochemistry.
SUBSTANCE: invention relates to molecular biology, specifically to proteins which regulate cell differentiation through inhibition of the TGF-beta cell superfamily. The invention is aimed at treating and preventing diseases related to human VgI orthologs. Noggin2 protein which contains VgI protein is injected into tissue in amount which is efficient for inhibiting VgI activity.
EFFECT: invention enables to solve the task of blocking the signal path activated by the TGF-beta factor of VgI in aniamal cells.
2 dwg, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF BLOCKING SINGALLING PATHWAY ACTIVATED BY TGF-beta FACTOR DERRIERE IN ANIMAL CELLS | 2009 |
|
RU2407799C1 |
| NOGGIN2-BASED ACTIVIN ACTIVITY BLOCKING METHOD | 2005 |
|
RU2354662C2 |
| METHOD FOR SIGNAL PATH BLOCKING ACTIVATED BY Wnt8 FACTORS IN ANIMAL CELLS BY MEANS OF NOGGIN FAMILY PROTEINS | 2011 |
|
RU2473561C1 |
| METHOD FOR PRODUCING POPULATION OF PANCREATIC ENDOCRINE CELLS CO-EXPRESSING NKX6.1 AND INSULIN, AND METHOD OF TREATING DIABETES | 2010 |
|
RU2701335C2 |
| DIFFERENTIATION OF HUMAN EMBRYONIC STEM CELLS | 2010 |
|
RU2610176C2 |
| DIFFERENTIATION OF HUMAN EMBRYO STEM CELLS | 2008 |
|
RU2473685C2 |
| METHOD OF CULTIVATION PLURIPOTENTIAL STEM CELLS | 2005 |
|
RU2375448C2 |
| DIFFERENTIATION OF HUMAN EMBRYONIC STEM CELLS | 2018 |
|
RU2782271C2 |
| DIFFERENTIATION OF HUMAN EMBRYONIC STEM CELLS | 2008 |
|
RU2465323C2 |
| DIFFERENTIATING HUMAN EMBRYONIC STEM CELLS | 2010 |
|
RU2540016C2 |
